tenofovir has been researched along with resveratrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Davis, CE; Foulke, JS; Heredia, A; Le, NM; Redfield, RR; Reitz, MS; Wainberg, MA; Wang, LX | 1 |
2 other study(ies) available for tenofovir and resveratrol
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Targeting of the purine biosynthesis host cell pathway enhances the activity of tenofovir against sensitive and drug-resistant HIV-1.
Topics: Adenine; Cells, Cultured; Drug Resistance, Viral; Drug Synergism; HIV-1; Host-Pathogen Interactions; Humans; Leukocytes, Mononuclear; Organophosphonates; Purines; Receptors, CCR5; Resveratrol; Reverse Transcriptase Inhibitors; Stilbenes; Tenofovir; Virus Replication | 2013 |